Literature DB >> 33540004

PLGA encapsulated γ-cyclodextrin-meropenem inclusion complex formulation for oral delivery.

Aun Raza1, Jared A Miles2, Fekade Bruck Sime1, Benjamin P Ross2, Jason A Roberts3, Amirali Popat4, Tushar Kumeria5, James R Falconer6.   

Abstract

Meropenem (MER) is one of the last resort antibiotics used to treat resistant bacterial infections. However, the clinical effectiveness of MER is hindered due to chemical instability in aqueous solution and gastric pH, and short plasma half-life. Herein, a novel multi-material delivery system based on γ-cyclodextrin (γ-CD) and poly lactic-co-glycolic acid (PLGA) is demonstrated to overcome these challenges. MER showed a saturated solubility of 14 mg/100 mL in liquid CO2 and later it was loaded into γ-CD to form the inclusion complex using the liquid CO2 method. The γ-CD and MER inclusion complex (MER-γ-CD) was encapsulated into PLGA by the well-established double emulsion solvent evaporation method. The formation of the inclusion complex was confirmed using FTIR, XRD, DSC, SEM, and 1H NMR and docking study. Further, MER-γ-CD loaded PLGA nanoparticles (MER-γ-CD NPs) were characterized by SEM, DLS, and FTIR. The drug loading and entrapment efficiency for MER-γ-CD were 21.9 and 92. 2% w/w, respectively. However, drug loading and entrapment efficiency of MER-γ-CD NPs was significantly lower at up to 3.6 and 42.1% w/w, respectively. In vitro release study showed that 23.6 and 27.4% of active (non-degraded drug) and total drug (both degraded and non-degraded drug) were released from MER-γ-CD NPs in 8 h, respectively. The apparent permeability coefficient (Papp) (A to B) for MER, MER-γ-CD, and MER-γ-CD NPs were 2.63 × 10-6 cm/s, 2.81 × 10-6 cm/s, and 2.92 × 10-6 cm/s, respectively. For secretory transport, the Papp (B to A) were 1.47 × 10-6 cm/s, 1.53 × 10-6 cm/s, and 1.58 × 10-6 cm/s for MER, MER-γ-CD and MER-γ-CD NPs, respectively. Finally, the MER-γ-CD inclusion complex and MER-γ-CD NPs retained MER's antibacterial activities against Staphylococcus aureus and Pseudomonas aeruginosa. Overall, this work demonstrates the significance of MER-γ-CD NPs to protect MER from gastric pH with controlled drug release, while retaining MER's antibacterial activity.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cyclodextrins; Liquid CO(2); Meropenem; Oral antibiotics; Oral drug delivery; PLGA nanoparticles

Mesh:

Substances:

Year:  2021        PMID: 33540004     DOI: 10.1016/j.ijpharm.2021.120280

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  4 in total

Review 1.  Cyclodextrin Inclusion Complexes with Antibiotics and Antibacterial Agents as Drug-Delivery Systems-A Pharmaceutical Perspective.

Authors:  Dariusz Boczar; Katarzyna Michalska
Journal:  Pharmaceutics       Date:  2022-06-30       Impact factor: 6.525

2.  Formulation and Biological Evaluation of Mesoporous Silica Nanoparticles Loaded with Combinations of Sortase A Inhibitors and Antimicrobial Peptides.

Authors:  Sitah Alharthi; Zyta M Ziora; Taskeen Janjua; Amirali Popat; Peter M Moyle
Journal:  Pharmaceutics       Date:  2022-05-04       Impact factor: 6.525

3.  Cyclic RGD functionalized PLGA nanoparticles loaded with noncovalent complex of indocyanine green with urokinase for synergistic thrombolysis.

Authors:  Sha Zhang; Jinjie Li; Jiefeng Ren; Zaiyao Xue; Xinlian Qi; Quanjin Si
Journal:  Front Bioeng Biotechnol       Date:  2022-08-10

4.  A PEGylated Nanostructured Lipid Carrier for Enhanced Oral Delivery of Antibiotics.

Authors:  Seyed Ebrahim Alavi; Urooj Bakht; Maedeh Koohi Moftakhari Esfahani; Hossein Adelnia; Seyed Hossein Abdollahi; Hasan Ebrahimi Shahmabadi; Aun Raza
Journal:  Pharmaceutics       Date:  2022-08-11       Impact factor: 6.525

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.